Abstract
The occurrence of paclitaxel (PTX) resistance in nonsmall cell lung cancer (NSCLC) is a major challenge for NSCLC treatment. Circular RNAs (circRNAs) ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
